OSIRIS THERAPEUTICS, INC.·4

Feb 16, 6:45 AM ET

FRIEDLI PETER 4

4 · OSIRIS THERAPEUTICS, INC. · Filed Feb 16, 2011

Insider Transaction Report

Form 4
Period: 2011-02-14
FRIEDLI PETER
Director10% OwnerOther
Transactions
  • Award

    Common Stock

    2011-02-14$7.13/sh+10,000$71,30010,106,794 total
Holdings
  • Common Stock

    (indirect: See Note)
    4,156,685
Footnotes (2)
  • [F1]Grant of 10,000 shares of common stock of Osiris Therapeutics, Inc. as compensation for service as Chairman of the Registrant's Board of Directors during the fiscal year ended December 31, 2010, made under the Amended and Restated 2006 Omnibus Plan.
  • [F2]The Reporting Person hold indirect beneficial ownership of 4,153,310 shares held by Venturetec, Inc., 2,750 shares held by his spouse and 625 shares held by his mother. The Reporting Person holds approximately a 3% interest in Venturetec, Inc. and serves as its president. The Reporting Person disclaims beneficial ownership in the shares held by his spouse and mother and disclaims beneficial interest in the shares held by Venturetec, Inc. beyond the extent of his pecuniary interest therein.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -